Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q5NUL3: Variant p.Arg67Cys

Free fatty acid receptor 4
Gene: FFAR4
Variant information Variant position: help 67 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Cysteine (C) at position 67 (R67C, p.Arg67Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help Genetic variations in FFAR4 define the body mass index quantitative trait locus 10 (BMIQ10) [MIM:607514]. Variance in body mass index is a susceptibility factor for obesity. Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.

Sequence information Variant position: help 67 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 361 The length of the canonical sequence.
Location on the sequence: help LVLIFAVSLLGNVCALVLVA R RRRRGATACLVLNLFCADLL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.



Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
Chain 1 – 361 Free fatty acid receptor 4
Topological domain 67 – 77 Cytoplasmic
Helix 43 – 69

Literature citations
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.
Hirasawa A.; Tsumaya K.; Awaji T.; Katsuma S.; Adachi T.; Yamada M.; Sugimoto Y.; Miyazaki S.; Tsujimoto G.;
Nat. Med. 11:90-94(2005)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; TISSUE SPECIFICITY; VARIANT CYS-67; Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.
Ichimura A.; Hirasawa A.; Poulain-Godefroy O.; Bonnefond A.; Hara T.; Yengo L.; Kimura I.; Leloire A.; Liu N.; Iida K.; Choquet H.; Besnard P.; Lecoeur C.; Vivequin S.; Ayukawa K.; Takeuchi M.; Ozawa K.; Tauber M.; Maffeis C.; Morandi A.; Buzzetti R.; Elliott P.; Pouta A.; Jarvelin M.R.; Korner A.; Kiess W.; Pigeyre M.; Caiazzo R.; Van Hul W.; Van Gaal L.; Horber F.; Balkau B.; Levy-Marchal C.; Rouskas K.; Kouvatsi A.; Hebebrand J.; Hinney A.; Scherag A.; Pattou F.; Meyre D.; Koshimizu T.A.; Wolowczuk I.; Tsujimoto G.; Froguel P.;
Nature 483:350-354(2012)
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.